小児重症血液学 腫瘍学 身体外生命維持のための紹介経路: 標準化された評価と移転は生存を改善することができます
Hitesh S Sandhu1, Kimberly Fan2, Samir Shah1
1From the Division of Pediatric Critical Care, Department of Pediatrics, University of Tennessee Health Sciences Center, Le Bonheur Children's Hospital, Memphis, Tennessee.
ASAIO journal (American Society for Artificial Internal Organs : 1992)
|August 27, 2025
まとめ
ECLSを必要とする小児患者の生存率を向上させた. この標準化されたアプローチにより 患者の治療成果が向上し 移植時の合併症も減少しました
科学分野:
- 小児重症治療薬
- 血液学と腫瘍学
- 身体外生命維持装置
背景:
- 血管外生命維持装置 (ECLS) の使用は,血液病/腫瘍病患者で増加しています.
- この集団におけるECLSの結果は着実に改善しています.
- 標準化された評価と転送プロトコルが必要です.
研究 の 目的:
- 身体外生命維持 (CHORPE) のためのクリティカル・ヘマトロジー・オンコロジー・リファール・パスウェイの開発と評価.
- ECLS候補者の早期評価と特定を標準化する.
- CHORPEの患者への影響と移植合併症の評価
主な方法:
- ECLSの評価のために移送された患者の遡及的チャートレビュー.
- CHORPE導入前のグループと CHORPE導入後のグループの成果の比較
- ECLSの配置,生存率,そして移植の合併症の分析
主要な成果:
- CHORPE後のグループは,脱術後の生存率 (OR=24, p=0. 01) と退院率 (OR=15. 9, p=0. 03) を著しく改善した.
- CHORPE後のグループでは,移植時の合併症が少なく見られた (p=0. 0228).
- 臨床的改善により,ECLSの導入後の患者数が減った (p=0. 0120).
結論:
- ECLSの候補者評価の標準化されたアプローチは生存率を改善します.
- 早期発見と安全な移送で 介護の継続は不可欠です
- CHORPEの導入は,ECLSの小児血液腫瘍学患者のより良い結果と関連しています.
さらに関連する動画
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.9K
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
430
関連する概念動画
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:22Bone Marrow Sampling and Transplants
493
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
493
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:24Hemodialysis II: Procedure and Complications
128
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
128
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K